New medicine shows potential to reduce oral steroid use in severe asthma patients

(McMaster University) The results of the trial, published this week in the New England Journal of Medicine, demonstrate that patients treated with a potential new medicine and antibody, called benralizumab, were more than four times likely to reduce their usage of oral corticosteroids than those taking a placebo.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news